Cargando…

Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease

BACKGROUND: Patients with adult congenital heart disease (ACHD) experience long waitlist times for heart transplantation (HTx) while a large proportion of donor hearts are refused. The goal of this study was to inform optimal donor selection for patients with ACHD listed for HTx by examining the imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Huntley, Geoffrey D., Danford, David A., Menachem, Jonathan, Kutty, Shelby, Cedars, Ari M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483491/
https://www.ncbi.nlm.nih.gov/pubmed/34238025
http://dx.doi.org/10.1161/JAHA.120.020248
_version_ 1784577140389314560
author Huntley, Geoffrey D.
Danford, David A.
Menachem, Jonathan
Kutty, Shelby
Cedars, Ari M.
author_facet Huntley, Geoffrey D.
Danford, David A.
Menachem, Jonathan
Kutty, Shelby
Cedars, Ari M.
author_sort Huntley, Geoffrey D.
collection PubMed
description BACKGROUND: Patients with adult congenital heart disease (ACHD) experience long waitlist times for heart transplantation (HTx) while a large proportion of donor hearts are refused. The goal of this study was to inform optimal donor selection for patients with ACHD listed for HTx by examining the impact of donor characteristics on post‐HTx outcomes. METHODS AND RESULTS: Using the Scientific Registry of Transplant Recipients, we conducted a retrospective analysis of patients aged ≥18 years listed for HTx in the United States between 2000 and 2016. We compared waitlist times between patients with ACHD and patients with noncongenital heart disease and constructed multivariate hazard models to identify donor characteristics associated with increased waitlist time. We then compared post‐HTx survival between patients with ACHD and patients with noncongenital heart disease and constructed multivariate hazard models to identify donor characteristics associated with mortality. There were very few differences in donor characteristics between HTx recipients with ACHD and those with noncongenital heart disease. Status 1A–listed patients with ACHD experienced longer waitlist times compared with patients with noncongenital heart disease. Increased wait times were associated with some donor characteristics. Post‐HTx outcomes varied over time, with patients with ACHD having inferior early mortality (0 to 30 days), similar intermediate mortality (31 days to 4 years), and superior late mortality (>4 years). We identified no donor characteristics associated with mortality to justify the observed differences in donor selection or waitlist time. CONCLUSIONS: HTx candidates with ACHD wait longer for transplant but do not require unique donor selection criteria. HTx teams should consider liberalizing donor criteria and focusing only on evidence‐based selection to improve waitlist outcomes and reduce the recipient–donor disparity.
format Online
Article
Text
id pubmed-8483491
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84834912021-10-06 Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease Huntley, Geoffrey D. Danford, David A. Menachem, Jonathan Kutty, Shelby Cedars, Ari M. J Am Heart Assoc Original Research BACKGROUND: Patients with adult congenital heart disease (ACHD) experience long waitlist times for heart transplantation (HTx) while a large proportion of donor hearts are refused. The goal of this study was to inform optimal donor selection for patients with ACHD listed for HTx by examining the impact of donor characteristics on post‐HTx outcomes. METHODS AND RESULTS: Using the Scientific Registry of Transplant Recipients, we conducted a retrospective analysis of patients aged ≥18 years listed for HTx in the United States between 2000 and 2016. We compared waitlist times between patients with ACHD and patients with noncongenital heart disease and constructed multivariate hazard models to identify donor characteristics associated with increased waitlist time. We then compared post‐HTx survival between patients with ACHD and patients with noncongenital heart disease and constructed multivariate hazard models to identify donor characteristics associated with mortality. There were very few differences in donor characteristics between HTx recipients with ACHD and those with noncongenital heart disease. Status 1A–listed patients with ACHD experienced longer waitlist times compared with patients with noncongenital heart disease. Increased wait times were associated with some donor characteristics. Post‐HTx outcomes varied over time, with patients with ACHD having inferior early mortality (0 to 30 days), similar intermediate mortality (31 days to 4 years), and superior late mortality (>4 years). We identified no donor characteristics associated with mortality to justify the observed differences in donor selection or waitlist time. CONCLUSIONS: HTx candidates with ACHD wait longer for transplant but do not require unique donor selection criteria. HTx teams should consider liberalizing donor criteria and focusing only on evidence‐based selection to improve waitlist outcomes and reduce the recipient–donor disparity. John Wiley and Sons Inc. 2021-07-09 /pmc/articles/PMC8483491/ /pubmed/34238025 http://dx.doi.org/10.1161/JAHA.120.020248 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Huntley, Geoffrey D.
Danford, David A.
Menachem, Jonathan
Kutty, Shelby
Cedars, Ari M.
Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease
title Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease
title_full Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease
title_fullStr Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease
title_full_unstemmed Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease
title_short Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease
title_sort donor characteristics and recipient outcomes after heart transplantation in adult congenital heart disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483491/
https://www.ncbi.nlm.nih.gov/pubmed/34238025
http://dx.doi.org/10.1161/JAHA.120.020248
work_keys_str_mv AT huntleygeoffreyd donorcharacteristicsandrecipientoutcomesafterhearttransplantationinadultcongenitalheartdisease
AT danforddavida donorcharacteristicsandrecipientoutcomesafterhearttransplantationinadultcongenitalheartdisease
AT menachemjonathan donorcharacteristicsandrecipientoutcomesafterhearttransplantationinadultcongenitalheartdisease
AT kuttyshelby donorcharacteristicsandrecipientoutcomesafterhearttransplantationinadultcongenitalheartdisease
AT cedarsarim donorcharacteristicsandrecipientoutcomesafterhearttransplantationinadultcongenitalheartdisease